Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Ur2 might want to the 9/30 notice of re-exam

Yes we agree. There will be more actions. My point is that the examiner has already reexamined the patent. He must in order to accept or deny the request for the reexamination. Once he grants the reexamination his decision is submitted to a panel for review and they will agree or disagree with his decision. We do not know the final outcome until the issuance of reexamination certificate.

Share
New Message
Please login to post a reply